Related Experiment Video
Updated: Nov 6, 2025
10:04
Enhancing Tumor Content through Tumor Macrodissection
Published on: February 12, 2022
11.2K
Genetic Events Inhibiting Apoptosis in Diffuse Large B Cell Lymphoma
Etienne Leveille1, Nathalie A Johnson2,3
1Faculty of Medicine, McGill University, Montreal, QC H3G 2M1, Canada.
Cancers
|May 5, 2021
Summary
Diffuse large B cell lymphoma (DLBCL) resistance to therapy is linked to apoptosis inhibition. Understanding these genetic events is key to developing targeted treatments that restore programmed cell death in malignant cells.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Diffuse large B cell lymphoma (DLBCL) is a curable lymphoma in approximately 65% of patients treated with chemoimmunotherapy.
- A key factor in DLBCL pathogenesis and therapeutic resistance is the inhibition of apoptosis, enabling malignant cell survival and further genetic alterations.
Purpose of the Study:
- To review the genetic events that inhibit apoptosis in DLBCL.
- To provide insights into the interactions of these events in lymphomagenesis.
- To discuss the implications for future DLBCL targeted therapies.
Main Methods:
- This review synthesizes information from existing literature on DLBCL.
- It focuses on genetic alterations affecting intrinsic and extrinsic apoptotic pathways.
- Mechanisms of apoptosis inhibition, including protein modulators and genetic dysregulations, are examined.
Main Results:
- Inhibition of apoptosis is a hallmark of DLBCL, driven by genetic events affecting apoptotic pathways and their regulators.
- Dysregulation occurs through various genetic mechanisms, including mutations, amplifications, deletions, and translocations affecting pro- and anti-apoptotic proteins.
- Key players in apoptosis inhibition include P53, NF-kB pathway components, and inhibitor of apoptosis proteins.
Conclusions:
- Understanding the genetic basis of apoptosis inhibition in DLBCL is critical for improving treatment outcomes.
- Targeted therapies aimed at restoring apoptosis hold promise for overcoming chemoimmunotherapy resistance.
- Further research into these mechanisms will guide the development of novel therapeutic strategies for DLBCL.
Related Concept Videos
01:31The Intrinsic Apoptotic Pathway
7.3K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
7.3K
02:23Abnormal Proliferation
4.8K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.8K
01:17The Extrinsic Apoptotic Pathway
7.0K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
7.0K
01:23Negative Regulator Molecules
37.1K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
37.1K
02:34Inhibition of Cdk Activity
5.2K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.2K
01:12Loss of Tumor Suppressor Gene Functions
5.4K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.4K